Dare Bioscience Stock

Dare Bioscience FCF/Debt

Free Cash Flow to Debt Ratio of Dare Bioscience (DARE) as of Sep 7, 2026.

FCF/Debt

0.00

Last updated:

Free Cash Flow to Debt Ratio of Dare Bioscience is 2026 0.00 . Free Cash Flow to Debt Ratio of Dare Bioscience was 2025 101.50 % . It decreases by % lower compared to the previous year.

The Dare Bioscience FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2014
-618.14 USD
Jan 1, 2015
-158.43 USD
Jan 1, 2016
-4,867.29 USD
Jan 1, 2020
-6,825.01 USD
Jan 1, 2023
-1,008.92 USD
Jan 1, 2024
101.50 USD
The Dare Bioscience FCF/Debt history
YEARFCF/DebtYoY
101.50 %-110.06%
-1,008.92 %-85.22%
-6,825.01 %+40.22%
-4,867.29 %+2,972.29%
-158.43 %-74.37%
-618.14 %—
Access this data via the Eulerpool API
Get Free API Key

Dare Bioscience Stock analysis

What does Dare Bioscience do? Dare Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dare Bioscience stock

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Dare Bioscience since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Dare Bioscience with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API
Get Free API Key

Leverage — Dare Bioscience

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Dare Bioscience